The selloff follows an earnings report by chip manufacturing equipment supplier ASML which indicated weaker-than-expected sales guidance for 2025, raising concerns

Many Wall Street analysts think the stock will deliver double-digit gains in the coming months. Wall Street's average price target could be overly cautious. Nvidia has delivered such massive gains in recent years that it's easy to overlook how the stock has performed over the short term.

Shares mostly advanced in Asia on Thursday after U.S. stocks rose following better-than-expected profit reports from Morgan Stanley, United Airlines and other big companies. Chinese markets fell back after officials in Beijing announced the government was expanding financing for housing projects to try to turn around a slump in the property market triggered by a crackdown on excessive borrowing by developers.

Markets were mostly lower in Asia on Wednesday after U.S. stocks pulled back from their records, dented by selling of technology and energy sector shares. Tokyo’s Nikkei 225 index fell 1.8% to 39,210.

Asian shares are mixed, with Hong Kong's benchmark down more than 4%, after Wall Street rolled to more records. U.S. futures edged higher while oil prices shed more than $3

The stock drop also reflect concerns on whether the hold would impact Novavax's partnership with French drugmaker Sanofi, according to one analyst. Novavax said a participant enrolled in a mid-stage study of the combination vaccine last month reported symptoms of motor neuropathy,

Novavax shares tumbled after the Food and Drug Administration put a clinical hold on its testing applications for a combined Covid-flu vaccine and standalone flu inoculation due to safety concerns. Fi

Novavax Inc.’s stock tumbled 19% early Wednesday after the company said the Food and Drug Administration has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates,